Key Senate panel proposes expanded pharma pricing penalties – STAT

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of online get-togethers and deadlines has returned. And so has volatility in the markets, which reminds us of what happened the last time Chicken Little claimed the sky was falling. The rejoinder, of course, is ‘sell sky.’ Or maybe not. In any event, here are a few tidbits to keep you focused. We hope your day is productive and profitable. Meanwhile, do keep in touch. …

A key U.S. Senate panel is expanding its plans to punish drug makers that hike prices faster than inflation, according to an internal Senate document described to STAT. The policy, which is being considered as part of efforts by Democrats to include drug-pricing reforms in a sweeping government spending package, has the potential to change the way pharmaceutical companies set launch prices for their medicines, and how they choose to adjust prices over time.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Most Related Links :
Business News Governmental News Finance News

Source link

Back to top button